Precision oncology company, Guardant Health, Inc., boasts a suite of innovative cancer diagnostic tools such as blood tests, data sets, and analytics to support its operations in the United States and around the world. Aside from its flagship Guardant360 product, the firm offers a broad range of diagnostic tests such as Guardant360 LDT, Guardant360 CDx, and GuardantINFINITY Test. Additionally, the firm offers an integrated software-based solution known as GuardantConnect to provide clinical and biopharmaceutical customers with actionable insights on patients treated with their assays. Furthermore, Guardant Health offers development services to biopharmaceutical companies and medical institutions that include companion diagnostic development, regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, and kits fulfillment. With its headquarters in Palo Alto, California, the company was founded in 2011.